Quick-Med Technologies, Inc.
QMDT · OTC
6/30/2013 | 3/31/2013 | 12/31/2012 | 9/30/2012 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -22.3% | 66.2% | -48.4% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 66.5% | 77% | 46.3% | 78% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -77% | 73.8% | -149.9% | -57.8% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | $0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -78.6% | 32.3% | -221.2% | -94.7% |
| EPS | -0.004 | 0.002 | -0.009 | -0.008 |
| % Growth | -287% | 124.7% | -20.8% | – |
| EPS Diluted | -0.004 | 0.002 | -0.009 | -0.008 |
| Weighted Avg Shares Out | 37 | 37 | 37 | 37 |
| Weighted Avg Shares Out Dil | 37 | 37 | 37 | 37 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | -$0 | $0 | $0 | $0 |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -36.9% | 86.2% | -139.7% | -52.5% |